Navigation Links
Pharmaceutical Manufacturing in China Industry Research Report – Now Available from IBISWorld
Date:2/2/2013

San Francisco, CA (PRWEB) February 02, 2013

Revenue for the Pharmaceutical Manufacturing industry in China is expected to increase at an annualized rate of 22.1% in the five years to 2012 to reach $78.8 billion, says IBISWorld. Growth has been largely driven by rising market demand and the rising income levels of consumers. In addition, over the past five years the government amended the rebate practices of hospitals for pharmaceutical and medicine products to limit overcharging and price gouging of consumers. In the past, many consumers could not afford to purchase medicine or see a doctor.

In recent years, concentration levels in the global pharmaceutical industry have increased as major players merged to minimize rising R&D costs, reduce development times and increase global marketing power. Within the Pharmaceutical Manufacturing industry in China, concentration is low, with the top four players accounting for 15.0% of total industry revenue in 2012. The industry's concentration level is expected to increase as small and inefficient players leave the industry and large players become more competitive, says IBISWorld.

The government will continue to implement policies to restrict and decrease medicine prices, allowing more consumers to purchase medicine when required. This will increase demand for the Pharmaceutical Manufacturing industry in China. Furthermore, future healthcare reforms will allow drugstores to surpass hospitals as the major distribution channel for pharmaceuticals, says IBISWorld.

For more information, visit IBISWorld’s Pharmaceutical Manufacturing in China industry report page.

Follow IBISWorld on Twitter: https://twitter.com/#!/IBISWorld
Friend IBISWorld on Facebook: http://www.facebook.com/pages/IBISWorld/121347533189

IBISWorld Industry Report Key Topics

The Pharmaceutical Manufacturing industry in China is primarily engaged in the manufacture of chemical medicinal and pharmaceutical products in various formats, including ampoules, tablets, capsules, vials, ointments, powders, solutions, suspensions and radioactive medicine. These products are then sold via pharmacies or distributed via hospitals. Biological and veterinary medicine products are not included in this industry.

Industry Performance
Executive Summary
Key External Drivers
Current Performance
Industry Outlook
Industry Life Cycle
Products & Markets
Supply Chain
Products & Services
Major Markets
Globalization & Trade
Business Locations
Competitive Landscape
Market Share Concentration
Key Success Factors
Cost Structure Benchmarks
Barriers to Entry
Major Companies
Operating Conditions
Capital Intensity
Key Statistics
Industry Data
Annual Change
Key Ratios

About IBISWorld Inc.
Recognized as the nation’s most trusted independent source of industry and market research, IBISWorld offers a comprehensive database of unique information and analysis on every US industry. With an extensive online portfolio, valued for its depth and scope, the company equips clients with the insight necessary to make better business decisions. Headquartered in Los Angeles, IBISWorld serves a range of business, professional service and government organizations through more than 10 locations worldwide. For more information, visit http://www.ibisworld.com or call 1-800-330-3772.

Read the full story at http://www.prweb.com/releases/china/pharmaceutical-mfg/prweb10381949.htm.


'/>"/>
Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Related medicine news :

1. Bactolac Pharmaceutical Weighs In With New Year’s Resolution Support with Full-Service Weight Control Products Process
2. Blue Door Pharma and Global Energy Markets Strike Global Export Agreement for Meningitis Vaccine and Pharmaceuticals
3. Devalued and distrusted: Can the pharmaceutical industry restore its broken image?
4. UBC professor wins Canadas top pharmaceutical research award
5. Edison Pharmaceuticals announces initiation of EPI-743 Phase 2B Leigh Syndrome Clinical Trial
6. Environmentally friendly chemistry important for manufacturing pharmaceuticals
7. Taiho Pharmaceutical unveils data on 8 novel anticancer compounds
8. Medical care presents update on pharmaceutical health services research
9. Scientists use sound waves to levitate liquids, improve pharmaceuticals
10. Pharmica Consulting to Hold HIT Conference for the Pharmaceutical Industry
11. Is it constitutional for states to regulate pharmaceutical gifts and meals to doctors?
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/10/2016)... St. Louis, Missouri (PRWEB) , ... February 10, ... ... 11-14, 2016, in San Diego, will bring together more than 200 of the ... in healthcare for the future. , “The true benefit of the Forum is ...
(Date:2/10/2016)... ... ... Gout is like no other joint pain. It strikes suddenly, like flicking on ... redness. It is triggered by the crystallization of uric acid within the joints. It ... to the February 2016 issue of Harvard Men's Health Watch. , The large joint ...
(Date:2/10/2016)... ... ... Armune BioScience signed a definitive agreement with ARCpoint Labs ... country. Launched in April of 2015, Apifiny is the only cancer specific, non-PSA blood ... exceeded 3,000 tests in 2015. Primary care physicians and urologists have utilized Apifiny to ...
(Date:2/10/2016)... ... February 10, 2016 , ... Pediatric ... in their patients. Research shows that the Goal Attainment Scale (GAS) captures 20% ... this challenge and learn more about the Goal Attainment Scale, Education Resources Inc. ...
(Date:2/10/2016)... ... February 10, 2016 , ... ... the Ohio Safety Congress and Expo event March 9-11, 2016. Hosted by Ohio's ... Convention Center. , As the longest running and largest worker's compensation event ...
Breaking Medicine News(10 mins):
(Date:2/10/2016)... MINNEAPOLIS , Feb. 10, 2016 Urologix, ... for the treatment of Benign Prostatic Hyperplasia (BPH), announces ... Ash Keswani , a medical device industry veteran ... of the Limited Liability Company.  ... and service lines, Cooled ThermoTherapy™ and Prostiva® RF Therapy, ...
(Date:2/10/2016)... , Feb. 10, 2016  Rich Pharmaceuticals, Inc. (OTC ... a 1-for-100 reverse split of its issued and outstanding ... trading on Thursday, February 11, 2016. The Company,s common ... CUSIP number 76303T308 and temporary ticker symbol "RCHAD". After ... under the ticker symbol (RCHA).  --> ...
(Date:2/10/2016)... -- Oxis International Inc. (OTC/QB: OXIS) announced today that the ... "clinical trial triumph" after one of the first patients ... Daniel Vallera , a research scientist ... --> Daniel Vallera , a research scientist ... --> An article on the University of ...
Breaking Medicine Technology: